annomontacin

from Annona montana & A. muricata; structure in first source

Also Known As:

cis-annomontacin; 2(5H)-Furanone, 5-methyl-3-(2,8,15-trihydroxy-15-(tetrahydro-5-(1-hydroxytridecyl)-2-furanyl)pentadecyl)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Leukemia L1210 07/01/1991 - "The cytotoxicities in vitro of annomontacin [I], annonacinone [2], and annonacin were measured against murine leukemia L1210, human breast adenocarcinoma MDA-MB231, and human breast carcinoma MCF7 cell lines and compared with adriamycin."
2.	Breast Neoplasms (Breast Cancer) 07/01/1991 - "The cytotoxicities in vitro of annomontacin [I], annonacinone [2], and annonacin were measured against murine leukemia L1210, human breast adenocarcinoma MDA-MB231, and human breast carcinoma MCF7 cell lines and compared with adriamycin."
3.	Adenocarcinoma 07/01/1991 - "The cytotoxicities in vitro of annomontacin [I], annonacinone [2], and annonacin were measured against murine leukemia L1210, human breast adenocarcinoma MDA-MB231, and human breast carcinoma MCF7 cell lines and compared with adriamycin."